Protalix BioTherapeutics
PLX
#9002
Rank
$0.19 B
Marketcap
$2.44
Share price
0.00%
Change (1 day)
71.83%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): $0.21

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.21. In 2025 the company made an earnings per share (EPS) of -$0.08000 a decrease over its 2024 EPS that were of $0.04000.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$0.21-362.5%
2025-$0.08000-300%
2024$0.04000-66.67%
2023$0.12-138.71%
2022-$0.31-50%
2021-$0.62181.82%
2020-$0.22-82.11%
2019-$1.23-31.67%
2018-$1.80-72.31%
2017-$6.50124.14%
2016-$2.90-147.54%
2015$6.10-290.63%
2014-$3.206.67%
2013-$3.00130.77%
2012-$1.30-69.77%
2011-$4.3019.44%
2010-$3.60-12.2%
2009-$4.1036.67%
2008-$3.00-37.5%
2007-$4.8050%
2006-$3.203.23%
2005-$3.10138.46%
2004-$1.30-74%
2003-$5.000%
2002-$5.00-50%
2001-$10.00233.33%
2000-$3.00-84.21%
1999-$19.00-24%
1998-$25.00-600%
1997$5.00-16.67%
1996$6.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.31 523.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$6.71 3,095.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-$0.11-152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.37 552.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel